Liver matrin-3 protects mice against hepatic steatosis and stress response via constitutive androstane receptor

• Autores principales: Xiao Cheng (Autor), Vijaya Bhaskar Baki (Autor), Matthew Moran (Autor), Baolong Liu (Autor), Jiujiu Yu (Autor), Miaoyun Zhao (Autor), Qingsheng Li (Autor), Jean-Jack Riethoven (Autor), Channabasavaiah B. Gurumurth (Autor), Edward N. Harris (Autor), Xinghui Sun (Autor)
• Formato: Libro
• Publicado: Elsevier, 2024-08-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Objective: The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise with the increasing obesity epidemic. Rezdiffra as an activator of a thyroid hormone receptor-beta is the only Food and Drug Administration approved therapy. As such, there is a critical n...